Xeltis Announces Latest Results from aXess Trials to be Presented at ...
Xeltis announces aXess trial results at the 46th Annual Charing Cross Symposium, showcasing a restorative conduit for hemodialysis vascular access. aXess creates long-term living vessels, improving patient experience by reducing reinterventions and infections. Presentations by Dr. Shahverdyan and Prof Dr. Moll highlight advancements and infection control in vascular conduits.
Reference News
Xeltis announces aXess trial results at the 46th Annual Charing Cross Symposium, showcasing a restorative conduit for hemodialysis vascular access. aXess creates long-term living vessels, improving patient experience by reducing reinterventions and infections. Presentations by Dr. Shahverdyan and Prof Dr. Moll highlight advancements and infection control in vascular conduits.